AI Oncology Treatment Planning Software

AI oncology treatment planning software is a clinical decision-support tool that helps oncology teams navigate the complexity of cancer treatment decisions. It does not choose treatment. Instead, it integrates the many inputs an oncologist must consider, clinical history, staging, pathology, and increasingly genomic and molecular data, and organizes them into a coherent picture. It then aligns potential options with recognized clinical guidelines, such as widely used oncology guidelines, and surfaces relevant treatment approaches and clinical trials along with the evidence behind them. This is especially valuable for molecular tumor boards reviewing complex cases, where synthesizing genomic findings with guidelines and trials is demanding. Because it draws on molecular data, it connects to precision medicine platforms, and trial options connect to trial matching. Critically, the software is decision support: it presents options and evidence transparently so the oncologist and team can evaluate them, and the treatment decision always rests with the treating clinician. Done well, it reduces the cognitive burden of complex cases and helps ensure relevant, guideline-concordant options are considered.

Taction Software delivers oncology treatment planning as a full engagement shaped to your program, whether you are a cancer center, an academic medical center, a health system oncology service, or a precision oncology program. We map your workflows, data sources, guidelines, and tumor board processes first, then build the modules that fit: clinical, pathology, and genomic data integration, guideline alignment, option and trial surfacing, evidence presentation, and tumor board support tools. Because the software must be trustworthy in a high-stakes setting, we design it to be transparent, showing why each option is surfaced and citing the guideline or evidence behind it, and we validate its behavior carefully. We connect trial options to matching capabilities and molecular data to precision medicine tooling. We build with oncology and clinical informatics review throughout, because domain accuracy is non-negotiable here. Every module is composable, so you can start with data integration and guideline-aligned surfacing and expand into full tumor board support over time. The goal is a tool oncologists trust to inform, not override, their judgment.

A well-designed oncology treatment planning tool delivers value that unaided review cannot, because cancer decisions require synthesizing more information than any clinician can hold at once, under time pressure. The clearest benefit is reduced cognitive burden: organizing clinical, pathology, and molecular data into a coherent picture lets the oncologist focus on judgment rather than data gathering. Guideline alignment helps ensure that relevant, guideline-concordant options are considered, supporting consistent, evidence-based care. Surfacing relevant trials expands options for patients who might benefit. For tumor boards, the software makes complex, multidisciplinary review more efficient and better documented. Evidence transparency lets the team evaluate options critically rather than accepting a black-box recommendation, which is essential for trust and safety. Because the oncologist decides, the tool captures these benefits without the risks of automated treatment decisions. For programs, it supports consistent, high-quality oncology care at scale. Over time, a trusted planning tool becomes part of how the team delivers thorough, evidence-based cancer care, with clinicians firmly in control.

Taction Software follows a rigorous, safety-first process suited to high-stakes clinical AI. We begin with discovery, documenting oncology workflows, data sources, guidelines, tumor board processes, and regulatory considerations. We then design an architecture for integrating clinical and molecular data, aligning with guidelines, and surfacing options with evidence, with transparency and clinician control built in from the start. Development runs in iterative sprints with oncology and clinical informatics review, because in this domain, subject-matter accuracy and safety outweigh everything else. We validate the software carefully, checking that surfaced options and evidence are accurate and guideline-concordant, and we design against automation bias so the tool informs rather than steers. Because a tool that supports treatment decisions may fall under medical-device or clinical decision support regulation depending on its design and claims, we design with the appropriate regulatory pathway and oversight in mind. We build monitoring for ongoing performance, aligned with our healthcare AI observability practice. Throughout, the treating clinician remains the decision-maker.

Oncology treatment planning is high-stakes clinical AI, so accuracy, transparency, security, and regulatory awareness are foundational. Taction Software builds on a HIPAA-aligned foundation, with encryption in transit and at rest, granular access controls, audit logging, and Business Associate Agreements where applicable, and heightened protection for genomic data. Our architecture integrates clinical and molecular data using standards like HL7, FHIR, and FHIR Genomics on healthcare-grade cloud. We design for transparency, surfacing the guideline or evidence behind every option, because a black box has no place in cancer treatment decisions, and we validate that surfaced options are accurate and guideline-concordant. Because software supporting treatment decisions may be subject to clinical decision support or medical-device regulation depending on its intended use, we design with the appropriate pathway, validation, and human oversight in mind, and we recommend confirming the regulatory approach for the specific intended use. We monitor performance over time, aligned with our healthcare AI observability practice. Above all, the oncologist decides; the software informs.

Taction Software is a US-based healthcare software company founded in 2013, with offices in Chicago, Cheyenne, Austin, and Sacramento. We build healthcare software exclusively, so clinical accuracy, data integration, and compliance are part of our default process rather than afterthoughts. We have delivered more than 200 healthcare projects, including EHR and EMR platforms such as Voyant Health, FDA-registered mobile applications, and behavioral health tools. That clinical and data depth matters in oncology planning, where accuracy, transparency, and integrating complex molecular and clinical data are essential and the stakes are high. We work as a candid, safety-first partner, building transparent decision support that respects clinician judgment and regulatory reality, never overselling automation in a domain where it does not belong. Our leadership brings deep, hands-on expertise, with our CEO contributing more than 20 years of personal experience in software and healthcare technology. Building with Taction means partnering with a team that has repeatedly taken healthcare software from concept to production in regulated settings.

Oncology treatment planning pricing depends on scope, data integration, guideline and evidence complexity, and validation needs. Taction Software scopes each engagement to your program, and typical ranges are as follows. A focused module or proof of concept, such as data integration with guideline-aligned option surfacing for a cancer type, generally falls between $40,000 and $80,000. A full treatment planning platform with molecular integration, evidence presentation, tumor board support, and validation typically ranges from $80,000 to $200,000. Enterprise programs across many cancer types with deep integration and rigorous validation start at $200,000 and up. Because validation and clinical review are essential in this domain, they are always in scope. Any regulatory pathway work is scoped separately with appropriate expertise. Final pricing follows a discovery phase. We provide clear, itemized estimates so you can validate value on a focused scope first.